The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 239, Issue 2, 2001, Pages 152-157

  Claerhout, Ilse ^a   Beele, Hilde ^a   Verstraete, Alain ^a   Van Den Broecke, Caroline ^a   Kestelyn, Philippe ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORTETRACYCLINE; CYCLOSPORIN A;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; CORRELATION FUNCTION; DRUG BLOOD LEVEL; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; MALE; NONHUMAN; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RAT; RECIPIENT; REGRESSION ANALYSIS; SURVIVAL TIME; TIME;

EID: 0035070425     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170000242     Document Type: Article

References (30)

1. The role of systemic cyclosporine dosing schedule on corneal allograft survival in the rat model
2. Leflunomide therapy following penetrating keratoplasty in the rat
3. Delay in corneal allograft rejection due to anti-CD4 antibody given alone and in combination with cyclosporine A and leflunomide
4. The mechanisms of action of cyclosporine
5. The major histocompatibility complex of the rat
6. Systemic cyclosporine in high risk keratoplasty. Short- versus long-term therapy
7. Systemic cyclosporine in high-risk keratoplasty: Long-term results
8. Corticosteroids in corneal graft rejection: Oral versus single pulse therapy
9. Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis
10. Topical cyclosporine A in the treatment of anterior segment inflammatory disease
11. Clinical and immunohistological studies of corneal rejection in the rat penetrating keratoplasty model
12. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat
13. Corneal transplantation: Immunologically privileged status
14. Topical cyclosporine therapy for ulcerative keratitis associated with rheumatoid arthritis
15. The relationship between total kidney cyclosporin A concentrations, trough drug levels and renal function in the rat following withdrawal of treatment
16. Chronic cyclosporin A therapy in rats
17. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye
18. Misoprostol with Cyclosporine A prolongs corneal allograft survival in an animal model
19. Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A
20. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: A prospective randomized clinical trial
21. Treatment with cyclosporin A, with low doses, in high-risk penetrating keratoplasties. A bi-centric study of 90 cases
22. Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats
23. Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. A retrospective study
24. The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts
25. Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate
26. Corneal transplantation: H'ow successful are we?
27. Cyclosporine monitoring by fluorescence polarization immunoassay
28. Pharmacokinetic profiles of cyclosporine in rats
29. Penetrating corneal transplantation in the inbred rat: A new model
30. Immunological analysis and treatment of Mooren's ulcer with cyclosporine A applied topically